JMPWA
IMVT icon

JP Morgan Private Wealth Advisors’s Immunovant IMVT Stock Holding History

JP Morgan Private Wealth Advisors’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		$230K Buy
+5,992
New +$135K ﹤0.01% 1587

Other funds holding IMVT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
AGM
Alpine Global Management New York $668M AUM 20.22% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

JP Morgan Private Wealth Advisors's IMVT Position: Q3 2023 in Review

JP Morgan Private Wealth Advisors opened a new position in Immunovant (IMVT) in Q3 2023: 5,992 shares worth $230K. The stake represents ﹤0.01% of the portfolio and ranks #1587 among its holdings.

181 funds tracked by Wall St. Rank hold IMVT as of Q3 2023.

  • JP Morgan Private Wealth Advisors held 5,992 shares of Immunovant worth $230K as of Q3 2023.
  • Immunovant was a new JP Morgan Private Wealth Advisors position in Q3 2023.
  • Immunovant made up ﹤0.01% of JP Morgan Private Wealth Advisors's portfolio in Q3 2023, its #1587 holding.
  • 181 funds tracked by Wall St. Rank held Immunovant as of Q3 2023.

Based on JP Morgan Private Wealth Advisors's 13F filing for Q3 2023, filed 8 Nov 2023.